ID
37123
Beschreibung
Study ID: 104864/502 Clinical Study ID: 104864/502 Study Title: An Open-Label, Multicenter, Randomized, Phase II Study of Oral Topotecan Daily x 5 Days vs. Oral Topotecan 5 Days On, 2 Days Off for 3 Weeks for Second-Line Treatment in Patients with Recurrent, Locally Advanced or Metastatic Cervical Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: N/A Study Indication: Cancer, Locally Advanced or Metastatic Cervical Cancer
Stichworte
Versionen (2)
- 03.07.19 03.07.19 -
- 03.07.19 03.07.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
3. Juli 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Oral Topotecan Daily x 5 Days vs. Oral Topotacan 5 Days On, 2 Days Off; 104864/502
Concomitant Medication
- StudyEvent: ODM
Beschreibung
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852 (Concomitant Agent)
Beschreibung
Concomitant Agent, Medication name
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2347852 (Concomitant Agent)
- UMLS CUI [1,2]
- C2360065 (Medication name)
- LOINC
- MTHU027854
Beschreibung
Concomitant Agent, Dosage, Unit
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2347852 (Concomitant Agent)
- UMLS CUI [1,2]
- C0178602 (Dosage)
- SNOMED
- 260911001
- LOINC
- LP7180-5
- UMLS CUI [1,3]
- C0439148 (Unit)
- SNOMED
- 767525000
Beschreibung
Concomitant Agent, Frequencies
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2347852 (Concomitant Agent)
- UMLS CUI [1,2]
- C0439603 (Frequencies (time pattern))
- SNOMED
- 272123002
- LOINC
- LP130485-8
Beschreibung
Concomitant Agent, Drug Administration Routes
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2347852 (Concomitant Agent)
- UMLS CUI [1,2]
- C0013153 (Drug Administration Routes)
- SNOMED
- 410675002
- LOINC
- LP40261-7
Beschreibung
Concomitant Agent, Disease
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2347852 (Concomitant Agent)
- UMLS CUI [1,2]
- C0012634 (Disease)
- SNOMED
- 64572001
- LOINC
- LP21006-9
Beschreibung
Concomitant Medication Start Date
Datentyp
date
Alias
- UMLS CUI [1]
- C2826734 (Concomitant Medication Start Date)
Beschreibung
Concomitant Medication End Date
Datentyp
date
Alias
- UMLS CUI [1]
- C2826744 (Concomitant Medication End Date)
Beschreibung
Concomitant Agent, Continuous
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C2347852 (Concomitant Agent)
- UMLS CUI [1,2]
- C0549178 (Continuous)
- SNOMED
- 255238004
- LOINC
- LA16902-1
Ähnliche Modelle
Concomitant Medication
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C2360065 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0439148 (UMLS CUI [1,3])
C0439603 (UMLS CUI [1,2])
C0013153 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
Keine Kommentare